Michael D. Casey Insider Profile
4 Followers
Michael D. Casey, Director at Sarepta Therapeutics, holds 0.00 shares in Celgene (Ticker: CELG), holds 0.00 shares in Abaxis Inc (Ticker: ABAX), holds 5.00K shares in Sarepta Therapeutics (Ticker: SRPT).
Michael D. Casey's Trading History
| CELGCelgene | Nov 22, 2019 | ― | Uninformative Sell | ― | $0.00 | |
| ABAXAbaxis Inc | Aug 02, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| SRPTSarepta Therapeutics | May 21, 2009 | Director | Uninformative Buy | ― | $80.35K | |
| DRRXDurect | ― | ― | ― | $0.00 |
You May Also Like
Michael D. Casey insider profile FAQ
What is the percentage of profitable transactions made by Michael D. Casey?
The percentage of profitable transactions made by Michael D. Casey is 75%.
What is the average return per transaction made by Michael D. Casey?
The average return per transaction made by Michael D. Casey is 0.00%.
What stocks does Michael D. Casey hold?
Michael D. Casey holds: SRPT, CELG, ABAX, DRRX stocks.
What was Michael D. Casey's most profitable transaction?
Michael D. Casey’s most profitable transaction was an Informative Sell of CELG stock on September 6, 2017. The return on the trade was 35.80%.
What is Michael D. Casey's role in Sarepta Therapeutics?
Michael D. Casey's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
